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Abstract 
BACKGROUND: Acute renal failure (ARF) is a serious disease characterised by a rapid loss of renal functions 
due to nephrotoxic drug or ischemic insult. The clinical treatment approach such as dialysis techniques and 
continuous renal enhancement have grown rapidly during past decades. However, there is yet no significant effect 
in improving renal function. Hypoxia-preconditioned mesenchymal stem cells (HP-MSCs) have positive effects on 
the in vitro survival and stemness, in addition to angiogenic potential.  
AIM: In this study, we aimed to analyse the effect of HP-MSCs administration in improving renal function, 
characterised by blood urea nitrogen (BUN) and creatinine level.  
METHODS: A group of 15 male Wistar rats weighing 250 g to 300 g were used in this study (n = 5 for each 
group). Rats were randomly distributed into 3 groups: Vehicle control (Veh) as a control group, HP-MSCs and 
normoxia MSCs (N-MSCs) as the treatment group. Renal function was evaluated based on the BUN and 
creatinine levels using the colourimetric method on day 5 and 13. The histological analysis using HE staining was 
performed on day 13.  
RESULTS: The result showed there is a significant decrease in BUN and creatinine level (p < 0.05). The 
histological analysis of renal tissue also showed a significant decrease between Veh and treatment group (p < 
0.05).  
CONCLUSION: Based on this study, we conclude that HP-MSCs have a superior beneficial effect than N-MSCs 
in improving renal function in an animal model of gentamicin-induced ARF. 
 
 
 
 
Introduction 
 
Acute renal failure (ARF) is a serious disease 
characterised by a rapid loss of renal functions due to 
the renal damage by the nephrotoxic drug (cisplatin, 
cyclosporine A, gentamicin) and renal ischemia [1]. 
Depending on the severity and duration of renal 
dysfunction, ARF disease has high morbidity and 
mortality rate caused by massive retention of the 
nitrogenous compounds that indicated by the increase 
of blood urea nitrogen (BUN) and creatinine level [2]. 
The clinical treatment approach of ARF such as 
dialysis techniques and continuous renal 
enhancement have grown rapidly during past decades 
[3]. However there is yet no significant effect in 
improving renal function [4]. Therefore, the alternative 
treatments for ARF disease remain a major issue.  
Stem cells transplantation has become an 
alternative and promising strategy in recent years in 
regenerating tissue damage including renal 
dysfunction of ARF. Among many kinds of stem cell, 
mesenchymal stem cells (MSCs) have several 
advantages distinguished to the others, such as their 
ease of isolation and harvest, no immunogenicity, 
abundant distribution and low tumour formation risk 
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[5]. MSCs are defined as a stromal cell that expresses 
specific markers such as CD44, CD73, CD90, CD105, 
and lack the expression of express hematopoietic 
markers, such as CD14 or CD11b, CD19 or CD79a, 
CD34, CD45 and HLA-DR [6]. Specifically, MSCs 
have multipotent differentiation capacity into various 
tissue lineages, including renal cells, in addition to 
self-renewal [7]. Several studies reported that 
transplanted-MSCs had been used to treat various 
types of injured tissues, including renal injury [8]. 
However, there are some limitations of MSCs 
transplantation [5], [6], [7] such as poor engraftment 
and low survival rate at injury area [9]. Therefore, it is 
critical to optimise the survival capacity of MSCs by 
modifying MSCs under certain stimulation. 
 HP-MSCs have positive effects on the in vitro 
stemness and survival capacity, in addition to 
angiogenic potential [10] that is mediated by hypoxia-
inducible factors (HIFs), such as HIF-1α and HIF-2α 
[10], [11], [12]. HP-MSCs have a role in increased 
migration and engraftment capacities after 
transplantation into the injury area compared to N-
MSCs as well as the extended lifespan [13], [14]. 
However, the role of HP-MSCs condition to improve 
the renal function of ARF remains unclear.  
In this study, we aimed to analyse the effect 
of HP-MSCs administration in improving BUN and 
creatinine level (renal function marker) as well as 
histological appearances in an animal model of 
gentamicin-induced ARF. 
 
 
Material and Methods 
 
ARF Animal Model and Experimental 
Design 
Fifteen male Wistar rats, weighing about 250-
300 g, were used in this study (n = 5 for each group). 
Rats were housed in a 12h light-dark cycle cages at 
24°C, with water and food ad-libitum. To generate 
ARF rat model, the rats were induced by gentamicin 
140 mg/kg/day for 10 days, i.p., Rats were randomly 
distributed into 3 groups: Vehicle control (Veh) 
receiving NaCl injection, Hypoxia preconditioned-
MSCs (HP-MSCs) receiving injection of 1 x 10
6 
cell, 
and Normoxic-MSCs (N-MSCs) receiving injection of 
1 x 10
6
 cell intraperitoneally as treatment group 
respectively. 
 
HUC-MSCs Isolation and Cultivation 
Ethical concern was acquired by the 
institutional review board of the committee ethic of the 
medical faculty, Sultan Agung Islamic University of 
Semarang, Indonesia. Human umbilical cord-MSCs 
(hUC-MSCs) were isolated from umbilical cords 
obtained from donors with written informed consent. 
The isolation and expansion of hUC-MSCs were 
performed as described previously [15]. Briefly, the 
cords were chopped into small pieces. Then, cord 
pieces were cultured in Dulbecco`s Modified Eagle 
Media (DMEM) (Sigma-Aldrich, Louis St, MO) 
supplemented with 10% Fetal Bovine Serum (FBS) 
(Gibco™ Invitrogen, NY, USA) and 1% 
antibiotic/antimycotic (Gibco™ Invitrogen, NY, USA) 
at 37°C and 5% CO2. The medium was renewed 
every 3 days. The cells were passaged with trypsin- 
EDTA after 80% confluence. The fourth passage cells 
were used for experiments. 
 
Characterzation of UC-MSCs 
HUC-MSCs-like were fixed with Cytofix
TM
 
fixation buffer (554655, BD Biosciences, Franklin 
Lakes, NJ, USA), and washed twice with stain buffer 
(554657, BD Biosciences). For the phenotype 
markers analysis, the cells were stained with 
phycoerythrin (PE) mouse anti-human CD44 (Clone 
G44-26, 555479; BD Biosciences), allophycocyanin 
(APC) mouse anti-human CD73 (Clone AD2, 560847; 
BD Biosciences), fluorescein isothiocyanate (FITC) 
mouse anti-human CD90 (Clone 5E10, 561969 BD 
Biosciences) and PerCP-Cy5.5.1 mouse anti-human 
CD105 (Clone 266, 560819, BD Biosciences) 
antibodies. Cells were stained with specific antibody 
for 30 minutes at room temperature, washed twice 
with stain buffer (554657, BD Biosciences) and 
examined with a BD FACSAria
TM
 II flow cytometer 
(BD Biosciences) and BD FACSDiva
TM 
software (BD 
Biosciences).  
 
Differentiation Assay 
HUC-MSCs-like at passage 4 were 
trypsinised and seeded at a concentration of 7.5 x 10
4 
in a 24-well culture plate with standard medium. After 
12 h incubation, hUC-MSCs were cultured in the 
medium of osteogenic differentiation containing 
DMEM (Sigma-Aldrich, Louis St, MO), supplemented 
with 10% FBS (Gibco™ Invitrogen, NY, USA), 10-7 
mol/L/ 0.1 μM dexamethasone, 10 mmol/L β 
glycerophosphate, and 50 μmol/L ascorbate-2-
phosphate (Sigma-Aldrich, Louis St, MO) in 5% CO2 
and at 37°C for 21 day incubation. The osteogenic 
differentiation analysis, cells were washed with PBS, 
and with Alizarin Red staining (Sigma-Aldrich Corp., 
St. Louis, MO, USA). 
 
HP-MSCs Preparation 
To prepare HP-MSCs, hUC-MSCs were 
cultivated under standard culture condition at fourth 
passage. After reached 80% confluence, the cells 
were transferred into a hypoxic chamber containing 
5% O2 and incubated for 24 h at 37°C CO2 5%, then 
collected for the following experiment.  
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Histological Analysis 
Rats were sacrificed by cervical dislocation at 
day 13 after transplantation. Renal samples were 
collected after surgery and fixed in 4% 
paraformaldehyde. Sections (4 μm thick) were 
prepared from each group of renal tissue with 
standard protocols and processed by hematoxylin and 
eosin (H & E) staining. Then, the slides were analysed 
and scored with a semi-quantitative scale by an 
experienced technician evaluating changes found in 
ARF as the reference [16]. By previous reports [17], 
the tubular injury was assessed based on the level of 
tubular dilatation, loss of brush border, tubular 
necrosis and cast formation. The average histological 
score was used to analyse the renal tissue 
morphology. 
 
Evaluation of renal function  
Renal function was evaluated based on the 
BUN and creatinine levels using the colourimetric 
method (Quanti Chrom TM assay kits). Blood samples 
were collected from each rat (n = 5 for each group) on 
day 5 and 13 to compare the serum chemistry profile. 
Measurement of BUN and creatinine level was 
performed with the standard protocol. 
 
Data Analysis 
Data were presented as the means ± SD. All 
calculations were carried out using IBM SPSS 22.0 
(IBM Corp., Armonk, NY, USA) was used for statistical 
analysis. The statistical significance of the differences 
between the groups was assessed using one way-
ANOVA and continued with Duncan post-hoc 
analysis. P values: **, P < 0.001. 
 
 
Result 
 
MSC characteristic 
At the end of the expansion, the cells were 
arranged in monolayers with spindle-shaped and 
fibroblast-like cells. The surface markers of hUC-
MSCs-like were analysed using Flow cytometry and 
revealed that these cells expressed high levels of 
CD44 (92.4%), CD73 (94.9%), CD90 (86.6%) and 
CD105 (96.8%). 
 
Figure 1: Immunophenotyping analysis of hUC-MSCs which was 
positive for CD44, CD73, CD90 and CD105
 
HUC-MSCs Isolation and Osteogenic 
Differentiation 
HUC-MSCs isolation was carried out based 
on the plastic adherent capability under standard 
conditions (37°C, 5% CO2). The cells showed 
fibroblast-like (spindle shape) and peculiar 
morphology (Figure 2A). Osteocyte differentiations 
were determined using a standard protocol. The 
calcium deposits were confirmed by Alizarin Red. The 
positive osteogenic cells under the microscope were 
stained bright red.  
 
Figure 2: a) HUC-MSCs-like showed fibroblast-like or spindle-
shaped characteristic (scale bar 100 μm); b) Osteogenic 
differentiation hUC-MSCs-like was evidenced by mineralised matrix 
formation using Alizarin red staining that showed by bright red 
colour (Scale bar 50 μm) 
 
Renal Function Analysis 
To ensure the ARF animal model, firstly we 
checked the level of BUN and creatinine of animal 
model before treatment for ARF confirmation. Then, 
after the treatment, the level of BUN and creatinine 
was analysed to compare the effect of HP-MSCs to N-
MSCs in ARF animal model. The result showed that 
there was a significant decrease in BUN and 
creatinine level on day 5 and 13 between all treatment 
group than veh (p < 0.05). However, the result of HP-
MSCs treatment is better than N-MSCs. 
 
Figure 3: The result showed the highest decrease in BUN level is 
on HP-MSCs (9911.4 ± 1316.8) at day 13. The level of creatinine 
also significant decrease on day 13 in HP-MSCs (0.817 ± 0.038) 
 
Histopathological analysis 
The histological analysis was performed by 
HE staining. The average histological score was used 
to analyse the renal tissue morphology. The results 
showed that the histological features of renal tissues 
treated with HP-MSCs and N-MSCs groups showed 
normal renal cells compared to the vehicle group 
(Figure 4) in which HP-MSCs showed better renal cell 
repair. 
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Figure 4: a) The histological analysis of renal tissue showed a 
significant decrease between and treatment group (p < 0.05). The 
HP-MCSs showed better result in decreasing inflammatory cells 
(0.333 ± 0.115) and cell necrosis (0.266 ± 0.305); b) Veh showed 
patchy necrosis and atrophy of distal and proximal tubules (yellow 
arrow), pyknotic nuclei (red arrow), bleeding (black arrow) and cell 
debris in the lumen (blue arrow); c) All treatment groups showed 
dense interstitial tissue infiltrate between tubules at 
corticomedullary junction 
 
 
Discussion 
 
ARF also was known as the acute renal injury 
is one of the serious renal diseases characterized by 
rapid deterioration of renal functions indicated by the 
accumulation of the nitrogenous compounds (urea 
and creatinine). Several studies reported that UC-
MSCs as attractive candidates for renal repair of ARF 
[17], [18] due to the most of renal tissues structure 
such as nephrons are derived from mesenchymal that 
is similar source to MSCs, in addition to they have 
potential role for releasing the molecule differentiation 
signalling to both nephrons and collecting duct [18], 
[19]. However, the transplanted MSCs have poor 
engraftment and survivability in the injury area. To 
enhance their therapeutic capacity, the activated 
MSCs using hypoxic condition is needed to augment 
their homing and survival in renal injury sites. To 
analyse the effect of MSCs under hypoxic condition in 
ameliorating renal function of ARF we used 
gentamicin-injected rats as established ARF 
experimental animal model according to a previous 
protocol. In this study, we transplanted the HP-MSCs 
into ARF rat models intraperitoneally then analyse the 
BUN and creatinine level as well as histological 
finding on day 5 and 13. Our study is the first to 
administrate HP-MSCs to ARF animal model. 
The biochemical result of pretreatment group 
showed marked impairment of the renal function of 
ARF that indicated by the plasma increase of BUN 
and creatinine level. The histological appearance also 
showed glomerular tuft shrinkage (damage) and 
haemorrhage; capsular space widened as well as 
pyknotic nuclei of the tubular cells (necrosis). These 
suggested that the all groups in this study were under 
ARF condition (BUN = 36.422 mg/dl and creatinine= 
2.46 mg/dl). 
In our study, we found that the level of BUN 
and creatinine were significantly decreasing at day 5 
and 13 in all group (p < 0.05). These were supported 
by our morphology finding which shown that there is a 
significantly decrease in damage, necrosis, and 
hemorrhagic of the renal cell on day 13 in all 
treatment group (Figure 4). However, the BUN and 
creatinine level of HP-MSCs is lower compared to N-
MSCs and morphological appearances as well. These 
suggested that the regeneration process of ARF that 
indicated by normal renal function has been well 
controlled in HP-MSCs group.  
Active inflammation release several 
inflammatory molecules that triggering proteolytic 
degradation of the most growth factors of regeneration 
process [20] however they release several chemokine 
molecules for attracting the exogenous circulating HP-
MSCs homing to damaged renal tissue of ARF. HP-
MSCs homing to renal injury area involved specific 
attractant molecules such as VEGF, HGF, integrin α4 
and integrin β1 forming very late antigen 4 (VLA-4), 
and stromal-derived factor-1 (SDF-1) [21] (Figure 5). 
Figure 5: The homing mechanism of MSCs in renal failure. Model of 
oxidative stress-induced inflammation has been controlled post-HP-
MSCs administration. The gentamicin induced-oxidative stress 
leads to inflammation in ARF. The interactions of ligands to MSCs 
receptor: (SDF-1 and HGF)-(CXCR4 and cMet) and (VCAM-1 and 
VEGF) – (VLA-4 and CD44) may trigger the binding of MSCs to 
target endothelial cells leading to the migration of MSCs to renal 
injury (homing phenomena). In this area, MSCs being activated and 
released anti-inflammatory molecules such as TGF-β, TSG-6, IL-10, 
IL-1ra, and PGE2 for controlling the inflammation process. Under-
controlled inflammation may trigger the alteration of inflammatory to 
proliferation phase that characterised by the secretion of 
regeneration molecule (growth factor). These were correlated to the 
formation of renal cells (glomerulus and tubules) into a normal 
arrangement 
 
HP-MSCs in renal tissue injury release anti-
inflammatory molecule such as TGF-β and IL-10 for 
suppressing the inflammation process then accelerate 
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the shifting of inflammation to the proliferation phase  
[22]. In this proliferation stage, HP-MSCs release 
several molecules such as VEGF, PDGF and HGF to 
actively induce the endogenous stem cells and cells 
surrounding to repair and regenerate the damaged 
tissue of ARF, known as a paracrine mechanism. On 
the other side, HP-MSCs also may differentiate and 
transdifferentiate into several renal cells as well as 
exosomes mechanism by donating their crucial 
vesicle to accelerate the regeneration of ARF. 
HGF has a crucial role as a mitogenic 
molecule to stimulate the proliferation of renal 
epithelial cell lines [23], including a rat visceral 
glomerular and proximal tubular cell in damage tissue 
of ARF by nephrotoxic drug administration (cisplatin, 
cyclosporine A, gentamicin) and renal ischemia [24], 
[25]. VEGF as a potent angiogenic factor and 
concurrently to PDGF have an essential role as potent 
mitogens in cell growth and regeneration of ARF [26]. 
All these cytokines play a role in the initiation phase of 
renal cell regeneration and prevention of apoptosis 
through Akt or ERK1/2 pathway activation [27]. This 
study has a limitation in which we do not analyse the 
molecule released by MSCs whether in inflammation 
or proliferation phase. Hence, the molecule anti-
inflammation and regeneration released by MSCs as 
well as homing mechanism still unclear. We also do 
not analyse another soluble factor that may affect to 
the regeneration process.  
In conclusion, HP-MSCs have superior 
beneficial effect than N-MSCs in ameliorating renal 
function and regeneration of ARF in an animal model 
of gentamicin-induced ARF. 
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